trial

Implementation of a Social and Mental Health Support to Promote Recovery in Five Mental Health Facilities in Paris Area

NCTId NCT05274126
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 300 (estimated)
Sponsored by Versailles Hospital
Primary completion 2025-05-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
300 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2022-05-01
Primary completion
2025-05-01
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Patient group/Passvers

Sponsors

Versailles HospitalLead Sponsor
Agence régionale de santé Ile de FranceCollaborator
UNION NATIONALE DE FAMILLES ET AMIS DE PERSONNES MALADES ET/OU HANDICAPÉES PSYCHIQUESCollaborator

Investigators

1
Christine Passerieux, ProfPrincipal Investigator

Sites

5 total
Argenteuil, FranceParis, FranceRambouillet, FranceRueil-Malmaison, FranceVersailles, France

Facts & assertions

4 sourced
Enrollment
300
Phase
NA
Primary Completion Date
2025-05-01
Status
UNKNOWN
relationships
The graph out of here
drug
Patient group/Passvers
drug
lead_sponsor
Versailles Hospital
company
collaborator
Agence régionale de santé Ile de France
company
UNION NATIONALE DE FAMILLES ET AMIS DE PERSONNES MALADES ET/OU HANDICAPÉES PSYCHIQUES
company
indication
Bipolar Disorder
indication
Severe Mental Disorder
indication
Schizophrenia
indication
investigator
Christine Passerieux, Prof
person